Tables
- TABLE 1
Patients’ characteristics
Age years 59.5 (30–86) Males/females n 11/5 Comorbidities Arterial hypertension 11 (68.7%) Type 2 diabetes mellitus 5 (31.2%) Malignancies 2 (12.5%) Pre-existing respiratory diseases 3 (18.7%) Other 6 (37.5%) Data at hospital admission Time between symptoms onset and admission days 5 (0–15) Reported symptoms Fever ≥38.0°C 14 (87.5%) Dyspnoea 14 (87.5%) Cough 7 (43.7%) Gastrointestinal symptoms 2 (12.5%) Other 3 (18.7%) Body temperature °C 37.5 (37.2–38.9) Blood gas analysis# PaO2 mmHg 69 (48–98) PaCO2 mmHg 31 (27–38) pH 7.46 (7.39–7.52) PaO2/FIO2 mmHg 329 (228–467) Laboratory findings Haemoglobin g·dL−1 13.8 (9.2–15.0) Red blood cells ×1012 per L 4.7 (3–0–5.4) White blood cells ×109 per L 8.6 (3.8–20.6) Neutrophils ×109 per L 7.2 (3.9–18.9) Lymphocytes ×109 per L 0.8 (0.4–2.0) Monocytes ×109 per L 0.4 (0.1–3.0) Platelets ×109 per L 231.0 (102.0–561.0) C-reactive protein g·dL−1 13.6 (1.1–37.5) Ferritin µg·L−1 371 (80–1364) D-dimer µg·L−1 1256 (197–4473) Respiratory support Oxygen 12 (75.0%) Positive end-expiratory pressure 7 (43.7%) High-flow nasal cannula 1 (6.2%) Noninvasive ventilation 0 (0%) Orotracheal intubation 0 (0%) Length of hospitalisation days 25 (8–49) Outcome Discharge home 14 (87.5%) Intensive care unit 0 (0%) Death 2 (12.5%) RT-PCR assays Nasopharyngeal swabs 66 (89.2%) BALF 6 (8.1%) Rectal swabs 2 (2.7%) RT-PCR repetitions during hospital stay/time from symptom onset days 3 16 (100%)/8 (2–20) 4 13 (81.2%)/18 (9–27) 5 9 (56.2%)/21 (10–27) 6 4 (25.0%)/24 (17–24) RT-PCR positive results¶ Patients 3 (18.7%) Testing 3 (4.1%) Anti-SARS-CoV-2 serum antibodies+ IgM 8 (88.9%) IgG 9 (100%) Time from symptom onset days 25 (20–35) Data are presented as median (range) or n (%), unless otherwise stated. FIO2: inspiratory oxygen fraction; PaO2: arterial oxygen tension; PaCO2: arterial carbon dioxide tension; BALF: bronchoalveolar lavage fluid. #: FIO2 0.21; ¶: after two first negative results; +: N=9.